Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

New data highlight how Heartflow's AI software drives major shifts in heart care
One of the study's most significant findings was that patients managed using the advanced AI software saw LDL cholesterol drops of 18.7 mg/dL, with a 15% reduction in their risk of a cardiac event. Even patients with no calcified plaque saw significant changes in care management.
First patient treated with BASILICA before valve-in-valve TAVR in a mechanically-expanded valve
A heart team chose to perform BASILICA before valve-in-valve TAVR in a failed Lotus device to help minimize the risk of complications. These scenarios will likely grow more and more common as patients outlive their TAVR valves.
AHA data challenge explores links between inflammation and heart disease
Are care teams doing enough to take on inflammation? The American Heart Association hopes this new research initiative can help answer that question, and many others.
FDA recalls real-time glucose monitors after 56 injuries
Receivers on active glucose monitors manufactured by Dexcom are reportedly failing to send alerts when a patient’s blood sugar levels are dangerously high or low. There have been no deaths linked to the malfunction.
What is chronic venous insufficiency? Cardiologist shares perspective on President Trump’s diagnosis
President Donald Trump has been diagnosed with chronic venous insufficiency. He underwent a complete evaluation due to swelling in his legs, the White House announced, and is in “excellent health” otherwise.

Cardiologists in Spain encountered an unexpected complication in a 78-year-old transcatheter aortic valve replacement (TAVR) patient, highlighting the experience in JACC: Cardiovascular Interventions.

TAVR valve’s spontaneous leaflet rupture highlights importance of long-term follow-up

Cardiologists believe this is the first time this exact complication has been reported. Even patients who present with no known risk factors, they said, should receive regular follow-up care to ensure such incidents do not go untreated.

Following a high-fat diet impacted one middle-aged man’s cardiovascular health so much that cholesterol appeared to start leaking out of his hands.

Cholesterol appears on man’s hands after he lived on diet of hamburgers, sticks of butter

The patient, who was primarily eating meat, cheese and entire sticks of butter, said the yellow nodules did not hurt in any way. His cholesterol level exceeded 1000 mg/dL at the time of treatment.

Heart transplant patients on Medicaid face a higher risk of major complications

In addition, researchers noted, five-year mortality was inferior for patients on Medicaid when compared to patients with any other type of insurance.

Alzheimer's and Parkinson's cause similar cognitive symptoms, but show opposing patterns on MRI

This new information on the pathogenesis of both conditions could be useful for the development of interventions targeted at slowing cognitive decline.

ACC.24 sign American College of Cardiology

American College of Cardiology announces late-breaking clinical trials for ACC.25

The presentations will cover a variety of topics, including coronary artery disease, semaglutide, artificial intelligence, TAVR, heart failure, PCI and much more. ACC.25 takes place March 29-31 in Chicago.

George Dangas, MD, 2023-24 president of SCAI, director of cardiovascular innovation at Mount Sinai Hospital, and director of the TCT meeting, explains key trends he sees in interventional cardiology.

New directions and trends in interventional cardiology

Interventional cardiology continues to evolve, driven by rapid advancements in technology. George Dangas, MD, discussed some of the specialty's biggest ongoing trends with Cardiovascular Business.

A majority of medical devices involved in Class I recalls were never required by the U.S. Food and Drug Administration (FDA) to undergo premarket or postmarket clinical testing, according to new research published in Annals of Internal Medicine.[1]

Valve durability after TAVR: Cardiologists track how deterioration influences outcomes

Researchers have made it a priority to learn as much about the durability of TAVR valves as possible. A new study in JACC: Cardiovascular Interventions used updated VARC-3 definitions to identify signs of hemodynamic valve deterioration in nearly 2,500 patients.

AI-powered heart assessments of NFL veterans could help cardiologists tackle CVD

Retired NFL players Joel Dreessen and Le-Lo Lang are among the first athletes participating in a new registry launched by HeartFlow and the Boone Heart Institute.

Clinical

New data highlight how Heartflow's AI software drives major shifts in heart care

First patient treated with BASILICA before valve-in-valve TAVR in a mechanically-expanded valve

AHA data challenge explores links between inflammation and heart disease

FDA recalls real-time glucose monitors after 56 injuries

What is chronic venous insufficiency? Cardiologist shares perspective on President Trump’s diagnosis